Zenas BioPharma stock slides 5% today as biotech shares sag; Phase 3 INDIGO data in focus
Zenas BioPharma shares dropped 5.2% to $37.03 in afternoon trading Tuesday, with about 123,000 shares changing hands. The decline followed broader weakness in biotech stocks and muted trading ahead of Federal Reserve minutes. The stock ranged from $36.94 to $40.50. No new company-specific news was reported.